R&D Sources Sought: Phase i Clinical Trials for Development of Neurotherapeutics Tender

Procurement Summary

Country : USA

Summary : R&D Sources Sought: Phase i Clinical Trials for Development of Neurotherapeutics

Deadline : 02 Dec 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 74833494

Document Ref. No. : 75N95023R00008

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

Description: This is a Research and Development (R&D) Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential R&D requirement.

This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only.

Background: The mission of the National Institute of Neurological Disorders and Stroke (NINDS) is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.

Purpose/Objective: The NINDS is interested in identifying organizations with requisite qualifications and capabilities to provide a full service, turn-key Phase I Clinical Trials Facility in support of the development of novel neurotherapeutic agents. This full-service facility is to perform a full range of services from protocol development through submission of final clinical study reports to be used by the NINDS and sponsored Investigators/Collaborators.

The emphasis of this Phase I Clinical Trials Facility will be to perform Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Phase I clinical trials utilizing NINDS-supplied novel agents developed by NINDS, sponsored Investigators or Contributors with an emphasis on first in human testing to determine the tolerated dose range, the dosing regimen, the safety profile and pharma...
Active Contract Opportunity
Notice ID : 75N95023R00008
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office : NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Sources Sought (Updated)
All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
Updated Published Date: Nov 18, 2022 05:53 pm EST
Original Published Date: Nov 18, 2022 05:46 pm EST
Updated Response Date: Dec 02, 2022 05:00 pm EST
Original Response Date: Dec 02, 2022 05:00 pm EST
Inactive Policy: 15 days after response date
Updated Inactive Date:
Original Inactive Date:
Initiative: None

Classification
Original Set Aside:

Product Service Code: AN12 - Health R&D Services; Health care services; Applied Research
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance:

Documents

 Tender Notice